The short answer
- Most carriers postpone 6 to 12 months after an event, then will look at you.
- Ejection fraction is the number that decides it - above 50 percent opens real options.
- Atrial fibrillation alone is mild - often standard, and far less costly than people fear.
- Congestive heart failure generally means guaranteed issue.
The phrase covers very different things
People arrive at this page having been told they have "heart problems" and assume that ends the conversation. It rarely does, because underwriters do not price the phrase. They price a specific event, a specific date and a specific set of test results.
A 62 year old with one stent placed four years ago, normal heart function and no further trouble is a materially different application from a 62 year old discharged last month after a second heart attack. Both would say they have heart disease.
The two numbers that matter most
Time since the event. Nearly every carrier postpones for six to twelve months after a heart attack, stent, bypass or new diagnosis. This is not a decline - it is a wait. Risk of a repeat event is highest immediately afterwards and falls steadily, and pricing follows that curve down for years.
Ejection fraction. EF is the percentage of blood your left ventricle pushes out with each beat, taken from an echocardiogram. It is the closest thing cardiac underwriting has to a single score:
- Above 50 percent - normal. Supports a genuine offer
- 40 to 50 percent - mildly reduced. Heavier rating
- Below 40 percent - significantly reduced. Usually simplified or guaranteed issue
If you do not know your EF, it is on your most recent echo report and it is the first thing worth finding out before anyone applies on your behalf.
What each history typically means
| History | Wait | Likely outcome |
|---|---|---|
| Atrial fibrillation only | None | Standard to mild rating |
| Single stent, stable | 6 - 12 months | Table rating, improves yearly |
| One heart attack, good recovery | 6 - 12 months | Moderate table rating |
| Bypass, uncomplicated | 12 months | Table rating, often good at 5 years |
| Repeated events or procedures | Varies | Simplified issue likely |
| Congestive heart failure | - | Guaranteed issue |
Stents versus bypass - the myth
People assume a bypass is automatically worse because it is bigger surgery. Underwriters do not see it that way. They look at how many vessels were involved, your heart function afterwards, and whether the problem came back. A single stent that has held for five years and a successful bypass five years out can price similarly. What genuinely worries an underwriter is repeat procedures - restenosis and repeated interventions signal progressive disease in a way that one definitive fix does not.
Atrial fibrillation is milder than you think
Afib generates more unnecessary worry than almost any cardiac diagnosis. Applicants hear "irregular heartbeat", assume the worst, and go straight to guaranteed issue - paying two or three times what they needed to.
In reality, atrial fibrillation with no underlying structural heart disease, properly managed and anticoagulated where clinically appropriate, is frequently approved at standard rates or a mild rating. Underwriters care whether it is lone afib or a symptom of something structural, whether rate or rhythm control is working, and whether stroke risk is being managed.
If afib is the only thing on your file, do not assume you are limited to no-questions cover. Get properly quoted first.
What improves your position
- Time. Rates genuinely fall with each stable year. A rating taken at 12 months can often be replaced at three or four years - reapply, and never cancel the old policy until the new one is in force
- Stopping tobacco. Cardiac history plus smoking is the most heavily penalised combination in underwriting. Most carriers want 12 months smoke free for non-tobacco pricing
- Controlling everything else. Blood pressure, cholesterol, diabetes and build are all assessed alongside the cardiac history, and they compound. See high blood pressure and diabetes
- Treating sleep apnea. Untreated apnea drives afib and hypertension, and underwriters know it. See sleep apnea
- Cardiac rehab and documented follow-up. Completed rehab and regular cardiology review read as a well-managed patient
Do this before anyone submits an application
Cardiac underwriting varies more between carriers than almost any other category, and a decline is disclosable on every future application for the rest of your life. That makes the order of operations more important than the paperwork.
Collect your most recent echocardiogram with the EF, your catheterisation or procedure report, any stress test results, and a current medication list. Then have an independent agent describe the case to several carriers informally - no application, no record - and find out who will take it before anything is formally submitted.
And never omit cardiac history. It is recoverable from medical records and prescriptions immediately, and non-disclosure gives an insurer grounds to contest a claim during the contestability period.
Common questions
Can I get life insurance after a heart attack?+
Yes. Most carriers postpone six to twelve months after the event, then will consider you. One heart attack with good recovery, preserved heart function and no further episodes usually results in a table rating rather than a decline.
What is ejection fraction and why does it matter?+
It is the percentage of blood your left ventricle pumps with each beat, from an echocardiogram. Above 50 percent is normal and supports a real offer. Between 40 and 50 draws a heavier rating. Below 40 usually means simplified or guaranteed issue.
Is a stent or a bypass worse?+
Neither automatically. Underwriters weigh how many vessels were involved, your heart function afterwards, and whether it recurred. A single stent with preserved function often prices better than repeated procedures, and a successful bypass can price well several years out.
Does afib stop me getting cover?+
Usually not. Atrial fibrillation with no underlying structural heart disease, properly managed and anticoagulated where appropriate, is often approved at standard or a mild rating. It is viewed far more mildly than most applicants expect.